novo nordisk compounded semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug Hims & Hers makes deal
Description
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Concomitantly, body weight-favorable therapeutic approaches are being dictated by the obesity ...
Article in the comments #GLP1 #FoodTrends #ConsumerBehavior #CulturalListening #Innovation #Ozempic #TrendForecasting #FMCG #CPGMarketing #FutureOfFood | 12 comments on LinkedIn
Verified seller
What Makes This Formula Special
